MSH2 and malignant colon neoplasm: Dr. Sekine delineated a cryptic nonfunctional in-frame EPCAM-MSH2 fusion protein resulting from a genomic rearrangement between EPCAM intron 5 and MSH2 intron 2 in one LS patient with aberrant cytoplasmic MSH2 localization in colon cancer (18).